MX2022011862A - Combinacion de un agente farmacologico y un agente de tratamiento no farmacologico para el tratamiento de trastornos neurologicos mediante entrenamiento de vias sinapticas. - Google Patents
Combinacion de un agente farmacologico y un agente de tratamiento no farmacologico para el tratamiento de trastornos neurologicos mediante entrenamiento de vias sinapticas.Info
- Publication number
- MX2022011862A MX2022011862A MX2022011862A MX2022011862A MX2022011862A MX 2022011862 A MX2022011862 A MX 2022011862A MX 2022011862 A MX2022011862 A MX 2022011862A MX 2022011862 A MX2022011862 A MX 2022011862A MX 2022011862 A MX2022011862 A MX 2022011862A
- Authority
- MX
- Mexico
- Prior art keywords
- synaptic
- pathway
- brain
- synaptic pathway
- training
- Prior art date
Links
- 230000037361 pathway Effects 0.000 title abstract 6
- 230000000946 synaptic effect Effects 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 208000012902 Nervous system disease Diseases 0.000 title 1
- 208000025966 Neurological disease Diseases 0.000 title 1
- 210000004556 brain Anatomy 0.000 abstract 4
- 230000002349 favourable effect Effects 0.000 abstract 2
- 208000028173 post-traumatic stress disease Diseases 0.000 abstract 2
- YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 abstract 1
- 206010026749 Mania Diseases 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 229960003299 ketamine Drugs 0.000 abstract 1
- 239000002831 pharmacologic agent Substances 0.000 abstract 1
- 230000001953 sensory effect Effects 0.000 abstract 1
- 230000004936 stimulating effect Effects 0.000 abstract 1
- 230000000638 stimulation Effects 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Social Psychology (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Addiction (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
Se describen métodos para tratar la depresión, manía, trastorno por estrés postraumático (PTSD), y diversas condiciones neurológicas usando entrenamiento de la vía sináptica. Los métodos de entrenamiento de la vía sináptica incluyen, generalmente, lograr un resultado de tratamiento favorable al activar una vía sináptica usando un agente farmacológico, tal como tratar los síntomas refractarios de la depresión con la ketamina, seguido de la potenciación del resultado favorable mediante la estimulación repetida de la vía activada. La estimulación de una vía sináptica se puede lograr mediante medios intrínsecos, tales como el desempeño de medios cognitivos ejercitados o extrínsecos, tales como la administración de un estímulo sensorial al paciente, al colocar una diferencia de voltaje potencial a lo largo del cerebro o una región del cerebro, o al colocar el cerebro o la región del cerebro en un campo magnético.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/827,546 US20200222656A1 (en) | 2016-10-18 | 2020-03-23 | Method for treatment of depression using synaptic pathway training |
| PCT/US2021/022517 WO2021194796A1 (en) | 2020-03-23 | 2021-03-16 | Method for treatment of neurological disorders using synaptic pathway training |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022011862A true MX2022011862A (es) | 2023-02-16 |
Family
ID=77890584
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022011862A MX2022011862A (es) | 2020-03-23 | 2021-03-16 | Combinacion de un agente farmacologico y un agente de tratamiento no farmacologico para el tratamiento de trastornos neurologicos mediante entrenamiento de vias sinapticas. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP4126199A4 (es) |
| BR (1) | BR112022019234A2 (es) |
| CA (1) | CA3172981A1 (es) |
| IL (1) | IL296693A (es) |
| MX (1) | MX2022011862A (es) |
| WO (1) | WO2021194796A1 (es) |
| ZA (1) | ZA202210356B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20230202978A1 (en) | 2022-03-04 | 2023-06-29 | Reset Pharmaceuticals, Inc. | Co-crystal or salt |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9064036B2 (en) * | 2008-04-24 | 2015-06-23 | The Invention Science Fund I, Llc | Methods and systems for monitoring bioactive agent use |
| WO2016004396A1 (en) * | 2014-07-02 | 2016-01-07 | Christopher Decharms | Technologies for brain exercise training |
| WO2016061320A2 (en) * | 2014-10-15 | 2016-04-21 | Rowan University | Timber therapy for post-traumatic stress disorder |
| WO2017180589A1 (en) * | 2016-04-11 | 2017-10-19 | Auspex Pharmaceuticals, Inc. | Deuterated ketamine derivatives |
| US10596378B2 (en) * | 2016-10-18 | 2020-03-24 | Joseph Rustick | Method for treatment of depression using synaptic pathway training |
| US20200222656A1 (en) * | 2016-10-18 | 2020-07-16 | Joseph Rustick | Method for treatment of depression using synaptic pathway training |
| AU2019262197A1 (en) * | 2018-05-04 | 2020-11-26 | Perception Neuroscience, Inc. | Methods of treating substance abuse |
-
2021
- 2021-03-16 CA CA3172981A patent/CA3172981A1/en active Pending
- 2021-03-16 EP EP21776197.2A patent/EP4126199A4/en active Pending
- 2021-03-16 WO PCT/US2021/022517 patent/WO2021194796A1/en unknown
- 2021-03-16 MX MX2022011862A patent/MX2022011862A/es unknown
- 2021-03-16 BR BR112022019234A patent/BR112022019234A2/pt unknown
- 2021-03-16 IL IL296693A patent/IL296693A/en unknown
-
2022
- 2022-09-19 ZA ZA2022/10356A patent/ZA202210356B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4126199A1 (en) | 2023-02-08 |
| CA3172981A1 (en) | 2021-09-30 |
| ZA202210356B (en) | 2023-02-22 |
| WO2021194796A1 (en) | 2021-09-30 |
| BR112022019234A2 (pt) | 2022-11-08 |
| EP4126199A4 (en) | 2024-04-10 |
| IL296693A (en) | 2022-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Suppa et al. | Ten years of theta burst stimulation in humans: established knowledge, unknowns and prospects | |
| Freire et al. | Neurostimulation in anxiety disorders, post-traumatic stress disorder, and obsessive-compulsive disorder | |
| Machado et al. | Is rTMS an effective therapeutic strategy that can be used to treat anxiety disorders? | |
| Machado et al. | Repetitive transcranial magnetic stimulation for clinical applications in neurological and psychiatric disorders: an overview | |
| JP2012522568A (ja) | 神経治療のための方法及びシステム | |
| Ruiz et al. | Current evidence on the potential therapeutic applications of transcranial magnetic stimulation in multiple sclerosis: a systematic review of the literature | |
| Danilov et al. | Emerging noninvasive neurostimulation technologies: CN-NINM and SYMPATOCORECTION | |
| MX2022011862A (es) | Combinacion de un agente farmacologico y un agente de tratamiento no farmacologico para el tratamiento de trastornos neurologicos mediante entrenamiento de vias sinapticas. | |
| Mann et al. | Repetitive transcranial magnetic stimulation | |
| Biagioni et al. | Non-invasive neuromodulation therapies for Parkinson’s disease | |
| Li et al. | Efficacy and practical issues of repetitive transcranial magnetic stimulation on chronic medically unexplained symptoms of pain | |
| Mattioli et al. | Non-invasive brain stimulation for patients and healthy subjects: Current challenges and future perspectives | |
| Park et al. | Effects of combining mental practice with electromyogram-triggered electrical stimulation for stroke patients with unilateral neglect | |
| Zimerman et al. | Brain stimulation and its role in neurological diseases | |
| Braga et al. | Somatic therapies for treatment-resistant psychiatric disorders | |
| Eggers et al. | 1Hz rTMS preconditioned by tDCS over the primary motor cortex in Parkinson’s disease: Absence of effect on arm lift and hand grip force control | |
| Janicak et al. | The efficacy of transcranial magnetic stimulation for major depression: a review of the evidence | |
| Malhi et al. | “Getting physical”: the management of neuropsychiatric disorders using novel physical treatments | |
| Demet et al. | Does acupuncture have a positive effect on school success in children? | |
| Kumru et al. | Modulation of brainstem reflexes induced by non-invasive brain stimulation: is there a future? | |
| Mahmoud Hewedi et al. | Effect of Repetitive Transcranial Magnetic Stimulation with High Frequency Versus low frequency on Motor Symptoms of Parkinson's Disease | |
| Milanov | Repetitive transcranial magnetic stimulation | |
| Litvinenko et al. | NEW TECHNOLOGIES IN TREATMENT AND REHABILITATION OF DISEASES AND INJURIES OF THE NERVOUS SYSTEM | |
| Dos Santos et al. | From Deep Brain Stimulation in Parkinson´ s Disease and treatment-resistant Depression to a new perspective to understand depression | |
| Sadeghi et al. | Design and evaluation of various tDCS electrodes and electrode placement to understand optimal configuration for treatment of depression |